INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Thomas Jefferson University
Filadelfia, Estados UnidosPublicaciones en colaboración con investigadores/as de Thomas Jefferson University (13)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 2, pp. 97-105
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
2017
-
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
Cancer Medicine, Vol. 6, Núm. 1, pp. 36-44
2016
2015
2014
-
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma
Biomarker Research, Vol. 2, Núm. 1
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
2005
-
Cone-like morphological, molecular, and electrophysiological features of the photoreceptors of the Nrl knockout mouse
Investigative Ophthalmology and Visual Science, Vol. 46, Núm. 6, pp. 2156-2167
2002
-
Elevated JNK activation contributes to the pathogenesis of human brain tumors
Oncogene, Vol. 21, Núm. 33, pp. 5038-5046
-
Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors
American Journal of Pathology, Vol. 160, Núm. 2, pp. 441-447
1995
-
Frequent Expression of a Mutant Epidermal Growth Factor Receptor in Multiple Human Tumors
Cancer Research, Vol. 55, Núm. 23, pp. 5536-5539